United States v. Harold Dean Behrens, James D. Wilkett, James M. Wilkett, and Fred Weed

689 F.2d 154
CourtCourt of Appeals for the Tenth Circuit
DecidedDecember 13, 1982
Docket81-1086, 81-1187, 81-1186 and 81-1253
StatusPublished
Cited by68 cases

This text of 689 F.2d 154 (United States v. Harold Dean Behrens, James D. Wilkett, James M. Wilkett, and Fred Weed) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Harold Dean Behrens, James D. Wilkett, James M. Wilkett, and Fred Weed, 689 F.2d 154 (10th Cir. 1982).

Opinion

SEYMOUR, Circuit Judge.

These consolidated appeals follow defendants’ convictions for conspiracy to unlawfully distribute narcotics in violation of 21 U.S.C. §§ 841(a)(1) and 846. Defendants seek reversal of the verdict against them primarily on grounds of prejudicial suppression of evidence by the prosecution, improper evidentiary determinations by the trial judge, and insufficiency of the evidence. We affirm.

I.

In October 1980, a federal grand jury indicted seven persons for conspiracy to illegally distribute the narcotic Dilaudid. The named defendants included Harold Behrens, Dr. Thomas Conklin, Joe Hoover, Harvey Mize, Fred Weed, James D. Wilkett, and James M. Wilkett. The case against Mize was subsequently dropped by the Government, and the trial court later severed the actions against Conklin and Hoover. The remaining defendants were found guilty following a jury trial.

The facts relevant to this appeal are derived from the testimony of unindicted co-conspirators and Government investigators, together with all reasonable inferences to be drawn therefrom, properly reviewed in the light most favorable to the prosecution. See United States v. Blitstein, 626 F.2d 774, 776 (10th Cir. 1980). The Wilkett defendants obtained large quantities of Dilaudid through prescriptions written by Dr. Conklin and filled by pharmacist Hoover. The Wilketts then distributed the Dilaudid to defendant Behrens and James Powell, an unindicted coeonspirator who was the Government’s primary witness. Behrens and Powell resold the drugs for profit. Bobby Weed, another unindicted coconspirator, frequently purchased Dilaudid from Behrens for illicit resale. Defendant Fred Weed loaned Bobby money for such purchases, directed Bobby to street customers for the drug, and took a percentage of Bobby’s profit.

Defendants raise myriad arguments in support of their appeals. Defendant Fred Weed asserts that the indictment is fatally defective. All defendants contend that the Government failed to timely- disclose exculpatory material. Defendants James D. Wilkett, James M. Wilkett, and Weed claim the trial judge erred by not adhering to the preferred order of proof vis-a-vis coconspirator hearsay, by not severing their cases from that of defendant Behrens, and by not declaring a mistrial after severing two defendants from the case. Defendants each separately assert various insufficiency of the evidence arguments as grounds for reversal of their convictions. Behrens and the Wilkett defendants also urge that evidence relating to prescriptions for Dilaudid, and the summaries of such evidence prepared by the Government, were erroneously admitted into evidence.

II.

A. The Indictment

The indictment charges that defendants and the unindicted coconspirators

“willfully and knowingly did conspire, confederate and agree together, with each other and with other persons unknown to the Grand Jury, to violate Title 21, United States Code, Section 841(a)(1), in that they combined, conspired, confederated and agreed to distribute a Schedule II narcotic controlled substance, to wit: Dilaudid, in violation of Title 21, United States Code, Section 846.”

Rec., vol. I, at 1 (emphasis added). The substantive offense set out in 21 U.S.C. § 841(a)(1), however, prohibits any person from “knowingly or intentionally” distributing a controlled substance. Relying on Robinson v. United States, 263 F.2d 911 (10th Cir. 1959), defendant Weed argues *158 that the indictment is fatally defective because it does not contain the “knowingly or intentionally” language. We have recently rejected an identical argument. See United States v. Perry, No. 81-1011, slip op. at 2-3 (10th Cir. July 6, 1982).

B. Exculpatory Evidence

Although all defendants made a general request for Brady material, the Government failed to produce prior to trial certain grand jury testimony and police statements containing exculpatory information indicating that Behrens obtained some Dilaudid from Texas. The Government erroneously treated this Brady material as Jencks material, required to be produced at trial rather than pretrial. See 18 U.S.C. § 3500(b). All of the material was produced during the course of the trial. Defendants concede the production but claim they were prejudiced by its untimeliness.

The prosecutorial duty to provide defense counsel with exculpatory evidence stems from the Supreme Court decision in Brady v. Maryland, 373 U.S. 83, 83 S.Ct. 1194, 10 L.Ed.2d 215 (1963). Brady prohibits suppression of material evidence favorable to an accused when disclosure is requested by the defense. Id. at 87, 83 S.Ct. at 1196. However, the rule applies in situations involving “defendant’s discovery, after trial, of information which had been known to the prosecution but unknown to the defense.” United States v. Agurs, 427 U.S. 97, 103, 96 S.Ct. 2392, 2397, 49 L.Ed.2d 342 (1976) (emphasis added). This circuit has previously concluded that Brady is not violated when the Brady material is available to defendants during trial. See United States v. Aiberico, 604 F.2d 1315, 1319 (10th Cir.), cert. denied 444 U.S. 992, 100 S.Ct. 524, 62 L.Ed.2d 422 (1979).

We do not condone the Government’s conduct in failing to liberally construe Brady in accordance with the trial judge’s continuing order to do so. Nevertheless, defendants have not demonstrated that the delayed disclosure of evidence deprived them of a fair trial. See United States v. Jackson, 579 F.2d 553, 560 (10th Cir.), cert. denied, 439 U.S. 981, 99 S.Ct. 569, 58 L.Ed.2d 652 (1978). Defendants correctly note that their attorneys’ trial strategy and cross-examinations might have been enhanced had the exculpatory material been provided earlier. The relevant standard of materiality, however, does not focus on trial preparation but instead on whether presentation of the evidence would have created a reasonable doubt of guilt that did not otherwise exist. Agurs, 427 U.S. at 112 n.20, 96 S.Ct. at 2401 n.20; Alberico, 604 F.2d at 1319. No such showing has been made by defendants in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Herrera
Tenth Circuit, 2022
Herrmann v. United States
129 Fed. Cl. 780 (Federal Claims, 2017)
Karen Wynkoop v. Gerard Stratthaus
2016 VT 5 (Supreme Court of Vermont, 2016)
William Edward Tuma v. Commonwealth of Virginia
Court of Appeals of Virginia, 2013
Commonwealth v. Tuma
Supreme Court of Virginia, 2013
Tuma v. Commonwealth
726 S.E.2d 365 (Court of Appeals of Virginia, 2012)
United States v. Thrower
746 F. Supp. 2d 303 (D. Massachusetts, 2010)
United States v. Burke
571 F.3d 1048 (Tenth Circuit, 2009)
Pueblo v. Velázquez Colón
174 P.R. 304 (Supreme Court of Puerto Rico, 2008)
United States v. Grigsby
272 F. App'x 738 (Tenth Circuit, 2008)
In Re Porter
374 B.R. 471 (D. Connecticut, 2007)
United States v. Blunt
187 F. App'x 821 (Tenth Circuit, 2006)
Whitney v. State
2004 WY 118 (Wyoming Supreme Court, 2004)
United States v. Falls
90 F. App'x 351 (Tenth Circuit, 2004)
United States v. Kouri-Perez
47 F. Supp. 2d 166 (D. Puerto Rico, 1999)
United States v. Scarborough
128 F.3d 1373 (Tenth Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
689 F.2d 154, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-harold-dean-behrens-james-d-wilkett-james-m-wilkett-ca10-1982.